Clarity Medical Supplements Executive Appointment: Cao Jian to Earn HK$0.85 Million as Finance VP, No Director’s Fee

Bulletin Express09-24

Clarity Medical Group Holding Limited has issued a supplemental announcement clarifying remuneration details for Mr. Cao Jian, whose appointment as Executive Director takes effect on 1 October 2026.

• Compensation structure: While Mr. Cao will not receive a director’s fee for his board role, he will be paid an annual salary of approximately HK$0.85 million in his concurrent position as Vice President of Finance. The package was set with reference to his duties, responsibilities, experience and prevailing market conditions, and remains subject to periodic review by the company’s remuneration committee and board.

• Unchanged matters: All other particulars disclosed in the original announcement dated 23 September 2026 remain the same, including the effective date of appointment.

• Current board composition: Executive Directors—Jiang Bo (also Chief Executive Officer) and Cao Jian; Non-Executive Directors—Chen Jiarong, Professor Wang Qinmei and Sun Peng; Independent Non-Executive Directors—Wang Can, Ci Ying, Dr. Chen Poujian and Xu Anliang.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment